Nongenomic Effects of Glucocorticoids, an Important Mechanism of Inhaled Glucocorticoids Action in Asthma

Alicja Grzanka; Jerzy Jarząb

doi:10.5603/ARM.27781

You are currently viewing a new version of our website. To view the old version click .

Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.

Review

12 August 2009

Nongenomic Effects of Glucocorticoids, an Important Mechanism of Inhaled Glucocorticoids Action in Asthma

and

Katedra i Oddział Kliniczny Chorób Wewnętrznych, Dermatologii i Alergologii w Zabrzu Śląskiego Uniwersytetu Medycznego w Katowicach, ul. M. Skłodowskiej-Curie 10, 41-800 Zabrze, Poland

Author to whom correspondence should be addressed.

Adv. Respir. Med.2009, 77(5), 453-459;https://doi.org/10.5603/ARM.27781

Version Notes

Order Reprints

Abstract

Authors describe the clinical implications of nongenomic effects of glucocorticoids, important also for the inhaled drugs. Data suggest that these rapid actions of glucocorticoids are important in the pharmacotherapy of asthma, particularly for prevention and treatment of acute exacerbations. Their influence on remodeling is also considered.

Keywords:

inhaled glucocorticoids; nongenomic action; asthma

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Resolvement of Respiratory Failure and Polycythemia after CPAP Treatment in a Middle-Aged Male with Severe Obstructive Sleep Apnea

Antiphospholipid Syndrome—An Update on Diagnosis and Treatment